About Us

KamTek, Inc. (KTI) is a proud Women-Owned Small Biotechnology Business headquartered in Frederick, Maryland. Since our incorporation on July 15, 1992, we have been committed to advancing the fields of biomedical research with a focus on quality, innovation, and excellence.  

 

Our expertise spans a wide range of scientific disciplines, including Molecular Biology, Microbiology, Cellular Services, and the Cryopreservation and Cryo-Storage of Biological Materials. With this legacy of over 30 years, we have established ourselves as a trusted partner for researchers, clinical organizations, and regulatory agencies by providing cutting-edge biorepository services and advanced laboratory solutions.

State-of-the-Art Facilities

KTI operates a 13,500 sq. ft. specialized biorepository and associated labs designed to meet FDA 21 CFR Part 211 guidelines. Our secure, 24/7-monitored facility is equipped to Receive, store, Process, manage and ship biospecimens under a wide range of temperature conditions, including: Room Temperature, 4°C, -20°C, -80°C, -170°C & -196°C.

 

 

Strategically located in the I-270 Technology Corridor, KTI is within an hour's drive of leading research and regulatory institutions such as the FDA, Johns Hopkins University, Walter Reed National Military Medical Center, NIH, and NCI, as well as numerous private research organizations.

What we do

At KTI, we specialize in Bio-Repository Operations and Laboratory Services designed to support our clients' research and development efforts.

Our offerings include:

 

Bio Storage Services

Storage and maintenance of research and clinical samples at stable optimal temperatures.

 

Cell Culture Services

EBV transformation of B-cells for expanded genetic material (e.g., DNA & RNA).

 

Biolab Services

Immunoassays, nucleic acid-based diagnostics, and next-generation sequencing (NGS).

 

Microbiome Studies

Analyses using 16S sequencing and whole genome sequencing (WGS) of fecal samples.

Short-term cultures and dysbiosis studies under varying conditions.

 

In-Vitro Antimicrobial Studies

 

Sample Processing Services

OUR MISSION

KamTek mission is to Promote biomedical research bridging new technologies with the established ones.

 

 

OUR VISION

Our vision is to push the boundaries of discovery and innovation to alleviate human suffering by empowering researchers through our services

 

 

Our Commitment

With decades of experience and a highly skilled team, KamTek, Inc. is dedicated to providing on time, high-quality services to meet the unique needs of the biomedical and biotechnology communities. Whether it’s managing sensitive biological materials or offering cutting-edge laboratory services, we strive to empower scientific discovery and innovation.

 

Let us help you take your research further.

Meeting the Highest standards.

KTI is proud to be managing its operations following

 

  • FDA cGMP compliance,
  • ISO 9001:2015 compliance,
  • ISBER best practices and NCI biosafety guidelines.

Core Team

Sharan VedBrat, PhD

President and Founder

  

Dr. Sharan VedBrat, formally trained as a cell biologist, has over 30 years of combined administrative and broad basic and applied biotech research expertise. She has undertaken business development, bio-technical and management operations of research activities, clinical laboratory and product development operations of federally as well as privately funded projects in the form of grants or contracts.  Dr. VedBrat technical expertise includes basic research in cell biology, carcinogenesis, retro-virology, immunology, microbiology and molecular biology. She has supervised multi-disciplinary staff, managed large-scale, multi-year national and international projects on cancer and AIDS research making significant contributions to these areas of biology.  In past years, she has been successful in securing and translating two separate SBIR grants into dedicated services offered by KTI to the greater life sciences community. She has always stayed at the cutting edge of technology and successfully procured and managed large corporate accounts.
 
Currently she has embarked upon antibiotic drug development program through repurposing of generic antibiotics. The first one is ‘EK101’ project that repurposes an old generic anti-leprosy, anti TB antibiotic Clofazimine (CFM) to tackle the national health emergency threat of Clostridium difficile infections (CDI) and associated potentially fatal disease (CDAD).  In the process, she has KamTek participate in antibiotic surveillance program by repurposing antibiotic with almost non-existent record of inducing resistance to tackle indication which is primarily a result of resistance to many antibiotics.  She has continued to make significant progress in this enterprise through getting KamTek IP rights and as one of the co-inventors on the patent, the use of SBIR program and NIH program, as well as, through private funding. Taking advantage of the I-Corps program, she has established consulting expertise in each and every area of drug development ecosystem reflected in team of associates of KTI.  She is intimately involved in planning strategies to commercialize CFM for CDAD and coordinates team activities and manages different functions of KTI in most judicious manner possible staying focused on the final goal and constantly moving the projects forward.

Ashok Dhawan, PhD

Vice President, Business and Technical Operations 

 

Dr. Ashok Dhawan has 35 years of experience in the areas of Biotechnology and Physiology. His widely respected discovery, as a part of the team at Australian National University, establishing the occurrence of “G-substances” as a new class of growth regulator, finds a place in classic text books. As a partner in National Mission projects of Government of India, his innovations lead to understanding of mechanisms of low temperature tolerance and development of PCR based markers to identify specific alleles of sucrose synthase-2 and invertase genes.  His work at the University of California Davis proposing a new mechanism for nitrate reduction has been widely acknowledged.  


He has been a Dean at the Central University of Punjab, Dean (Academic) National Institute of Food Technology Entrepreneurship and Management, and Director (Technical) in the Haryana State Department of Science and Technology.  He has published 143 research papers and presented 75 papers at conferences around the globe, including as lead speaker at World Biotechnology Congress, Chicago. A scientist of renown, he is a Fellow of two professional bodies and has been conferred with Neol Deer Award (2008) by President of India A. P. J. Abdul Kalam.  With his wide vision and deep understanding of research and administrative needs of R and D organizations, Dr. Dhawan leads KamTek in certain aspects of technical operations, business development and commercialization plans.